Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy

Bioconjugate Chemistry

Volumn 14, Issue 1, 2003, Pages 158-167

  Shukla, Supriya ^a   Wu, Gong ^a   Chatterjee, Madhumita ^a   Yang, Weilian ^a   Sekido, Masaru ^a   Diop, Lamine A ^b   Müller, Rainer ^a   Sudimack, Jennifer J ^a   Lee, Robert J ^a   Barth, Rolf F ^a   Tjarks, Werner ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b University Saint Boniface   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRIMERS; DISEASES; MAMMALS; ORGANIC ACIDS; TUMORS;

3RD GENERATION; BIOLOGICAL EVALUATION; BORON NEUTRON CAPTURE THERAPY; BORON NEUTRONCAPTURE THERAPY; C57BL/6 MICE; FOLATE RECEPTOR; FOLIC ACIDS; PAMAM DENDRIMER; POLYAMIDOAMINE DENDRIMERS; SYNTHESIS EVALUATION;

POLYETHYLENE GLYCOLS;

AMINE; BORON 10; DENDRIMER; FOLATE RECEPTOR; FOLIC ACID; MACROGOL; POLYAMIDOAMINE; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER; CONJUGATE; COVALENT BOND; DRUG DISTRIBUTION; DRUG TARGETING; DRUG UPTAKE; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER; MALE; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; PHARMACODYNAMICS; RETICULOENDOTHELIAL SYSTEM; SARCOMA;

ANIMALIA; MURINAE;

EID: 12244271024     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc025586o     Document Type: Article

References (66)

1. Soloway, A. H., Tjarks, W., Barnum, B. A., Rong, F. G., Barth, R. F., Codogni, I. M., and Wilson, J. G. (1998) The chemistry of neutron capture therapy. Chem. Rev. 98, 1515-1562.
2. Barth, R. F., Soloway, A. H., Goodman, J. H., Gahbauer, R. A., Gupta, N., Blue, T. E., Yang, W., and Tjarks, W. (1999) Boron neutron capture therapy of brain tumors: an emerging therapeutic modality. Neurosurgery 44, 433-450.
3. 10B-neutron capture therapy: Enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: A theoretical evaluation. Int. J. Radiat. Oncol., Biol., Phys. 11, 831-840.
4. Barth, R. F., Adams, D. M., Soloway, A. H., Alam, F., and Darby, M. V. (1994) Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy. Bioconjugate Chem. 5, 58-66.
5. Liu, L., Barth, R. F., Adams, D. M., Soloway, A. H., and Reisfeld, R. F. (1996) Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors. Anticancer Res. 16, 2581-2588.
6. Guan, L. F., Wims, L. A., Kane, R. R., Smuckler, M. B., Morrison, S. L., and Hawthorne, M. F. (1998) Homogeneous immunoconjugates for boron neutron-capture therapy: Design, synthesis, and preliminary characterization. Proc. Natl. Acad. Sci. U.S.A. 95, 13206-13210.
7. Gedda, L., Olsson, P., Ponten, J., and Carlsson, J. (1996) Development and in vitro studies of epidermal growth factordextran conjugates for boron neutron capture therapy. Bioconjugate Chem. 7, 584-591.
8. Yang, W., Barth, R. F., Adams, D. M., and Soloway, A. H. (1997) Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors. Cancer Res. 57, 4333-4339.
9. Barth, R. F., Yang, W., Adams, D. M., Rotaru, J. H., Shukla, S., Sekido, M., Tjarks, W., Fenstermaker, R. A., Ciesielski, M., Nawrocky, M. M., and Coderre, J. A. (2002) Molecular targeting of the epidermal growth factor receptor for the neutron capture therapy of gliomas. Cancer Res. 62, 3159-3166.
10. 8] as a potential agent for boron neutron capture therapy. Proc. Natl. Acad. Sci. U.S.A. 96, 6406-6410.
11. Hawthorne, M. F., and Kelly, S. (1997) Liposomes as drug delivery vehicles for boron agents. J. Neuro-Oncol. 33, 53-58.
12. Yanagie, H., Tomita, T., Kobayashi, H., Fujii, Y., Nonaka, Y., Saegusa, Y., Hasumi, K., Eriguchi, M., Kobayashi, T., and Ono, K. (1997) Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy. Br. J. Cancer 75, 660-665.
13. Pan, X. Q., Wang, H., Shukla, S., Sekido, M., Adams, D. M., Tjarks, W., Barth, R. F., and Lee, R. J. (2002) Boroncontaining folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy. Bioconjugate Chem. 13, 435-442.
14. Sudimack, J. J., Adams, D., Rotaru, J., Shukla, S., Yan, J., Sekido, M., Barth, R. F., Tjarks, W., and Lee, R. J. (2002) Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy. Pharm. Res. 19, 1502-1508.
15. Kullberg, E. B., Bergstrand, N., Carlsson, J., Edwards, K., Johnsson, M., Sjoeberg, S., and Gedda, L. (2002) Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents. Bioconjugate Chem. 13, 737-743.
16. Ishida, O., Maruyama, K., Tanahashi, H., Iwatsuru, M., Sasaki, K., Eriguchi, M., and Yanagie, H. (2001) Liposomes bearing poly(ethylene glycol)-coupled transferrin with intracellular targeting property to the solid tumors in vivo. Pharm. Res. 18, 1042-1048.
17. Leamon, C. P., and Low, P. S. (2001) Folate-mediated targeting: From diagnostics to drug and gene delivery. Drug Discov. Today 6, 44-51.
18. Sudimack, J., and Lee, R. J. (2000) Targeted drug delivery via the folate receptor. Adv. Drug Delivery Rev. 41, 147-162.
19. (a) Tomalia, D. A., Naylor, A. M., and Goddard, W. A., III. (1990) Starburst dendrimers: Control of size, shape, surface chemistry, topology and flexibility in the conversion of atoms to macroscopic materials. Angew. Chem., Int. Ed. Engl. 102, 119-157.
20. (b) http://www.dendritech.com/pamam.html.
21. Esfand, R., and Tomalia, D. A. (2001) Poly(amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical application. Drug Discov. Today 6, 427-436.
22. Stiribara, S. E., Frey, H., and Haag, R. (2002) Dendritic polymers in biomedical applications: From potential to clinical use in diagnostic and therapy. Angew. Chem., Int. Ed. Engl. 41, 1329-1334.
23. Kojima, C., Kono, K., Maruyama, K., and Takagishi, T. (2000) Synthesis of polyamidoamine dendrimers having poly (ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjugate Chem. 11, 910-917.
24. Yoo, H., and Juliano, R. L. (2000) Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAM-AM dendrimers. Nucleic Acids Res. 28, 4225-4231.
25. Luo, D., Haverstick, K., Belcheva, N., Han, E., and Saltzman, W. M. (2002) Poly(ethylene glycol)-conjugated PAMAM dendrimer for biocompatible, high-efficiency DNA delivery. Macromolecules 35, 3456-3462.
26. Kobayashi, H., Sato, N., Hiraga, A., Saga, T., Nakamoto, Y., Ueda, H., Konishi, J., Togashi, K., and Brechbiel, M. W. (2001) 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties. Magn. Reson. Med. 45, 454-460.
27. Kobayashi, H., Kawamoto, S., Saga, T., Sato, N., Hiraga, A., Ishimori, T., Konishi, J., Togashi, K., and Brechbiel, M. W. (2001) Positive effects of poly(ethylene glycol) conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents. Magn. Reson. Med. 46, 781-788.
28. Konda, S. D., Aref, M., Wang, S., Brechbiel, M., and Wiener, E. C. (2001) Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. Magn. Reson. 12, 104-113.
29. Konda, S. D., Wang, S., Brechbiel, M., and Wiener, E. C. (2002) Biodistribution of a 153Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenografts. Invest. Radiol. 37, 199-204.
30. Margerum, L. D., Campion, B. K., Koo, M., Shargill, N., Lai, J.-J., Marumoto, A., and Sontum, P. C. (1997) Gadolinium(III) DO3A macrocycles and poly(ethylene glycol) coupled to dendrimers. Effect of molecular weight on physical and biological properties of macromolecular magnetic resonance imaging contrast agents. J. Alloys Compd. 249, 185-190.
31. Kobayashi, H., Wu, C., Kim, M.-K., Paik, C. H., Carrasquillo, J. A., and Brechbiel, M. W. (1999) Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with antitac monoclonal antibody. Bioconjugate Chem. 10, 103-111.
32. 14 to cascade molecules. Angew. Chem., Int. Ed. Engl. 33, 666-668.
33. Qualmann, B., Kessels, M. M., Musiol, H. J., Sierralta, W. D., Jungblut, P. W., and Moroder, L. (1996) Synthesis of boron-rich lysine dendrimers as protein labels in electron microscopy. Angew. Chem., Int. Ed. Engl. 35, 909-911.
34. Kobayashi, H., Kawamoto, S., Saga, T., Sato, N., Ishimori, T., Konishi, J., Ono, K., Togashi, K., and Brechbiel, M. W. (2001) Avidin-dendrimer-(1B4M-Gd)(254): A tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI. Bioconjugate Chem. 12, 587-593.
35. Kono, K., Liu, M., and Fréchet, J. M. J. (1999) Design of dendritic macromolecules containing folate or methotrexate residues. Bioconjugate Chem. 10, 1115-1121.
36. Alam, F., Soloway, A. H., Barth, R. F., Mafune, N., Adams, D. M., and Knoth, W. H. (1989) Boron neutron capture therapy: Linkage of a boronated macromolecule to monoclonal antibodies directed against tumor-associated antigens. J. Med. Chem. 32, 2326-2330.
37. 131I-labeled epidermal growth factor in the pig visualized by dynamic scintigraphy. J. Endocrinol. 144, 5-12.
38. Chapman, A. P. (2002) PEGylated antibodies and antibody fragments for improved therapy: A review. Adv. Drug Delivery Rev. 54, 531-545.
39. Greenwald, R. B. (2001) PEG drugs: An overview. J. Controlled Release 74, 159-171.
40. Mastrobattista, E., Koning, G. A., and Storm, G. (1999) Immunoliposomes for the targeted delivery of antitumor drugs. Adv. Drug Delivery Rev. 40, 103-127.
41. Monfardini, C., and Veronese, F. M. (1998) Stabilization of substances in circulation. Bioconjugate Chem. 9, 418-450.
42. Allen, T. M., Austin, G. A., Chonn, A., Lin, L., and Lee, K. C. (1991) Uptake of liposomes by cultured mouse bone marrow macrophages: Influence of liposome composition and size. Biochim. Biosphys. Acta 1061, 56-64.
43. Hansen, C. B., Kao, G. Y., Moase, E. H., Zalipsky, S., and Allen, T. M. (1995) Attachment of antibodies to sterically stabilized liposomes: Evaluation, comparison and optimization of coupling procedures. Biochim. Biophys. Acta 1239, 133-144.
44. Suzuki, S., Watanabe, S., Masuko, T., and Hashimoto, Y. (1995) Preparation of long-circulating immunoliposomes containing adriamycin by a novel method to coat immunoliposomes with poly(ethylene glycol). Biochim. Biophys. Acta 1245, 9-16.
45. Woodle, M. C., Matthay, K. K., Newman, M. S., Hidayat, J. E., Collins, L. R., Redemann, C., Martin, F. J., and Papahadjopoulos, D. (1992) Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochim. Biophys. Acta 1105, 193-200.
46. Ladd, D. L., and Snow, R. A. (1993) Reagents for the preparation of chromophorically labeled poly(ethylene glycol)-protein conjugates. Anal. Biochem. 210, 258-261.
47. Lee, S., Winnik, M. A., Whittal, R. M., and Li, L. (1996) Synthesis of symmetric fluorescently labeled poly(ethylene glycols) using phosphoramidites of pyrenebutanol and their characterization by MALDI mass spectrometry. Macromolecules 29, 3060-3072.
48. Montaudo, G., Montaudo, M. S., Puglisi, C., and Samperi, F. (1995) Characterization of polymers by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: molecular weight estimates in samples of varying polydispersity. Rapid Commun. Mass Spectrom. 9, 453-460.
49. Zalipsky, S., Mullah, N., Harding, J. A., Gittelman, J., Guo, L., and DeFrees, S. A. (1997) Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains. Bioconjugate Chem. 8, 111-118.
50. Wu, K. J., and Odom, R. W. (1998) Characterizing synthetic polymers by MALDI MS. Anal. Chem. News Features, 456A-461A.
51. Barth, R. F., Adams, D. M., Soloway, A. H., Mechetner, E. B., Alam, F., and Anisuzzaman, A. K. (1991) Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy. Anal. Chem. 63, 890-893.
52. Hwu, P., Yang, J. C., Cowherd, R., Treisman, J., Shafer, G. E., Eshhar, Z., and Rosenberg, S. A. (1995) In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes. Cancer Res. 55, 3369-3373.
53. Lee, R. J., and Low, P. S. (1994) Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269, 3198-3204.
54. Lee, R. J., and Low, P. S. (1995) Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim. Biophys. Acta 1233, 134-144.
55. 99mTc-HYNIC-folate: A novel receptor-based targeted radiopharmaceutial for tumor imaging. J. Nucl. Med. 40, 1563-1569.
56. Capala, J., Barth, R. F., Bendayan, M., Lauzon, M., Adams, D. M., Soloway, A. H., Fenstermaker, R. A., and Carlsson, J. (1996) Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors. Bioconjugate Chem. 7, 7-15.
57. Tomalia, D. A., Naylor, A. M., and Goddard, W. A., III (1990) Starburst dendrimers: Control of size, shape, surface chemistry, topology and flexibility in the conversion of atoms to macroscopic materials. Angew. Chem., Int. Ed. Engl. 102, 119-157.
58. a of anilinium and nitroanilinium ions. J. Chem. Soc. B 922-928.
59. Gabizon, A., Horowitz, A. T., Goren, D., Tzemach, D., Mandelbaum-Shavit, F., Qazen, M. M., and Zalipsky, S. (1999) Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: In vitro studies. Bioconjugate Chem. 10, 289-298.
60. Roberts, J. C., Bhalgat, M. K., and Zera, R. T. (1996) Preliminary biological evaluation of polyamidoamine (PAMAM) starburst(TM) dendrimers. J. Biomed. Mater. Res. 30, 53-65.
61. Wilbur, D. S., Pathare, P. M., Hamlin, D. K., Buhler, K. R., and Vessella, R. L. (1998) Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers. Bioconjugate Chem. 9, 813-825.
62. Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., Jr., and Kamen, B. A. (1992) Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52, 3396-3401.
63. 125I-labeled polyamidoamine dendrimers in vivo. J. Controlled Release 65, 133-148.
64. Hristova, K., and Needham, D. (1995) Physical properties of polymer-grafted bilayers. Stealth Liposomes (D. Lasic, and M. Martin, Eds.) pp 35-49, CRC Press, Inc., Boca Raton.
65. MacIntosh, T. J., Kenworthy, A. K., and Needham, D. (1995) Measurement of the range and magnitude of the repulsive pressure between PEG-coated liposome. Stealth Liposomes (D. Lasic, and F. Martin, Eds.) pp 63-71, CRC Press, Inc., Boca Raton.
66. Torchilin, V. P., Papisov, M. I., Bogdanov, A. A., Trubetskoy, V. S., and Omelyanenekov, V. G. (1995) Molecular mechanism of liposome and immunoliposome steric protection with poly (ethylene glycol): Theoretical and experimental proof of the role of polymer chain flexibility. Stealth Liposomes (D. Lasic, and F. Martin, Eds.) pp 51-62, CRC Press, Inc., Boca Raton.